Clinical Trial Update: Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of hyperbaric oxygen therapy for long COVID (post-acute sequelae of SARS-CoV-2 infection) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Karolinska University Hospital | Conditions: COVID-19, Post COVID-19 Condition | Phase 2 | Status: COMPLETED